About TechsoMed
TechsoMed is a company based in Rehovot (Israel) founded in 2012.. TechsoMed has raised $9.6 million across 3 funding rounds from investors including Screen Holdings, European Union and Axil Capital. TechsoMed offers products and services including BioTrace and BioTrace.IO. TechsoMed operates in a competitive market with competitors including Butterfly Network, Exo, Zonare Medical Systems, SonoSite and Monteris, among others.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Techsomed Medical Technologies Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.6 M (USD)
in 3 rounds
-
Latest Funding Round
$7 M (USD), Series B
Mar 03, 2021
-
Investors
Screen Holdings
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TechsoMed
TechsoMed offers a comprehensive portfolio of products and services, including BioTrace and BioTrace.IO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for predicting tissue response in ablation therapy.
Tool for planning and confirming treatments in oncology.
Unlock access to complete
Unlock access to complete
Funding Insights of TechsoMed
TechsoMed has successfully raised a total of $9.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $7.0M
-
First Round
First Round
(30 May 2019)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series B - TechsoMed | Valuation | Axil Capital | |
| Dec, 2019 | Amount | Grant - TechsoMed | Valuation |
investors |
|
| May, 2019 | Amount | Series A - TechsoMed | Valuation | Johnson & Johnson Innovation |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TechsoMed
TechsoMed has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Screen Holdings, European Union and Axil Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are targeted by Axil Capital, a VC firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment firm backed by the Cohen family
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TechsoMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TechsoMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Techsomed Comparisons
Competitors of TechsoMed
TechsoMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, Zonare Medical Systems, SonoSite and Monteris, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| domain | founded_year | HQ Location |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| domain | founded_year | HQ Location |
Portable ultrasound systems are developed and provided for medical use.
|
|
| domain | founded_year | HQ Location |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| domain | founded_year | HQ Location |
MRI-guided laser ablation tools for neurosurgery are developed.
|
|
| domain | founded_year | HQ Location |
Deep learning-based imaging diagnostics for heart diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Techsomed
Frequently Asked Questions about TechsoMed
When was TechsoMed founded?
TechsoMed was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Where is TechsoMed located?
TechsoMed is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Is TechsoMed a funded company?
TechsoMed is a funded company, having raised a total of $9.6M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.6M, raised on May 30, 2019.
What does TechsoMed do?
TechsoMed was founded in 2012 in Rehovot, Israel, and operates in the medical technology sector. Real-time monitoring systems based on ultrasound are developed for thermal ablation procedures. The Biotrace unit, an imaging and analysis tool, is interfaced with standard ultrasound devices to track and predict tissue destruction progression. Operations focus on enabling precise control during ablation treatments in clinical settings.
Who are the top competitors of TechsoMed?
TechsoMed's top competitors include Butterfly Network, Exo and Zonare Medical Systems.
What products or services does TechsoMed offer?
TechsoMed offers BioTrace and BioTrace.IO.
Who are TechsoMed's investors?
TechsoMed has 11 investors. Key investors include Screen Holdings, European Union, Axil Capital, Yongjin Group, and Cobro Ventures.